Lucentis and Pregnancy

No clinical studies have been conducted on Lucentis and pregnancy; therefore, the drug has been given a pregnancy Category C rating (meaning there are potential risks involved). Since Lucentis is used for treating a condition that generally affects older people, it is unlikely that a young woman would take the drug. However, if you are taking Lucentis and pregnancy occurs, alert your healthcare provider immediately.

Lucentis For Macular Degeneration

Lucentis and Pregnancy: An Overview

It is unknown if Lucentis^® (ranibizumab) is safe for use during pregnancy. It is a medication used for wet macular degeneration, a condition that most likely affects older people.

Lucentis and Pregnancy Category C

The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but that do appear to cause harm to fetuses in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.

Lucentis was given a pregnancy Category C rating because it has not been studied at all in any pregnant women or animals.

Lucentis and Pregnancy: Final Thoughts

If you are pregnant or are thinking of becoming pregnant while taking Lucentis, let your healthcare provider know. He or she will consider the benefits and risks of using the medication during pregnancy before making a recommendation in your particular situation.